HK1085926A1 - Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis - Google Patents

Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis

Info

Publication number
HK1085926A1
HK1085926A1 HK06106009A HK06106009A HK1085926A1 HK 1085926 A1 HK1085926 A1 HK 1085926A1 HK 06106009 A HK06106009 A HK 06106009A HK 06106009 A HK06106009 A HK 06106009A HK 1085926 A1 HK1085926 A1 HK 1085926A1
Authority
HK
Hong Kong
Prior art keywords
bradykinin
receptor antagonists
treating osteoarthrosis
osteoarthrosis
treating
Prior art date
Application number
HK06106009A
Other languages
English (en)
Inventor
Martin Michaelis
Karl Rudolphi
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1085926A1 publication Critical patent/HK1085926A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06106009A 2003-02-07 2006-05-25 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis HK1085926A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (de) 2003-02-07 2003-02-07 Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
PCT/EP2004/000550 WO2004069266A2 (de) 2003-02-07 2004-01-23 Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose

Publications (1)

Publication Number Publication Date
HK1085926A1 true HK1085926A1 (en) 2006-09-08

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106009A HK1085926A1 (en) 2003-02-07 2006-05-25 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis

Country Status (31)

Country Link
EP (1) EP1594520B1 (xx)
JP (1) JP2006516980A (xx)
KR (1) KR20050105447A (xx)
CN (1) CN1317029C (xx)
AR (1) AR043036A1 (xx)
AT (1) ATE335500T1 (xx)
AU (1) AU2004210396A1 (xx)
BR (1) BRPI0407333A (xx)
CA (1) CA2514152C (xx)
CO (1) CO5690613A2 (xx)
CY (1) CY1105708T1 (xx)
DE (2) DE10304994A1 (xx)
DK (1) DK1594520T3 (xx)
ES (1) ES2268622T3 (xx)
HK (1) HK1085926A1 (xx)
HR (1) HRP20050701B1 (xx)
IL (1) IL169899A0 (xx)
MA (1) MA27618A1 (xx)
ME (1) MEP41008A (xx)
MX (1) MXPA05007310A (xx)
MY (1) MY135827A (xx)
NO (1) NO333903B1 (xx)
NZ (1) NZ541680A (xx)
PE (1) PE20040939A1 (xx)
PL (1) PL206412B1 (xx)
PT (1) PT1594520E (xx)
RS (1) RS51029B (xx)
RU (1) RU2329057C2 (xx)
TW (1) TW200505472A (xx)
WO (1) WO2004069266A2 (xx)
ZA (1) ZA200505177B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
EP1496835A4 (en) * 2002-02-01 2006-10-18 Omeros Corp COMPOSITIONS AND METHODS FOR THE SYSTEMIC SUPPRESSION OF CARTON DECOMPOSITION

Also Published As

Publication number Publication date
DK1594520T3 (da) 2006-12-11
JP2006516980A (ja) 2006-07-13
HRP20050701A2 (en) 2006-09-30
EP1594520B1 (de) 2006-08-09
BRPI0407333A (pt) 2006-01-10
CN1747742A (zh) 2006-03-15
ZA200505177B (en) 2006-11-29
MA27618A1 (fr) 2005-11-01
TW200505472A (en) 2005-02-16
PL376605A1 (pl) 2006-01-09
NO20054144L (no) 2005-09-06
MEP41008A (en) 2011-02-10
AU2004210396A1 (en) 2004-08-19
CY1105708T1 (el) 2010-12-22
NO333903B1 (no) 2013-10-14
CO5690613A2 (es) 2006-10-31
DE502004001159D1 (de) 2006-09-21
WO2004069266A3 (de) 2004-09-30
DE10304994A1 (de) 2004-09-02
IL169899A0 (en) 2011-08-01
HRP20050701B1 (hr) 2014-01-03
PL206412B1 (pl) 2010-08-31
AR043036A1 (es) 2005-07-13
PE20040939A1 (es) 2005-01-17
PT1594520E (pt) 2006-11-30
CA2514152A1 (en) 2004-08-19
RS20050565A (xx) 2007-09-21
RS51029B (sr) 2010-10-31
RU2005127862A (ru) 2006-01-27
MY135827A (en) 2008-07-31
ES2268622T3 (es) 2007-03-16
RU2329057C2 (ru) 2008-07-20
EP1594520A2 (de) 2005-11-16
CN1317029C (zh) 2007-05-23
ATE335500T1 (de) 2006-09-15
WO2004069266A2 (de) 2004-08-19
MXPA05007310A (es) 2005-09-30
CA2514152C (en) 2012-01-17
NZ541680A (en) 2009-07-31
KR20050105447A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
HK1079451A1 (en) Use of compounds that are effective as selective opiate receptor modulators
IL175025A0 (en) Therapeutic regimens for baff antagonists
HK1090922A1 (en) Cgrp receptor antagonists cgrp
IL165197A0 (en) N-substituted tricyclic 3-aminopyrzoles as fdfg receptor inhibitors
NO20051871D0 (no) Opioid reseptorantagonister
IL176069A0 (en) Cbi antagonist compounds
ZA200408335B (en) Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors.
IL175084A0 (en) Antagonists of the bradykinin b1 receptor
IL173512A0 (en) Cyclopropyl derivatives as nk3 receptor antagonists
EP1641781A4 (en) BENZODIAZEPINE CGRP RECEPTOR ANTAGONISTS
AU2003238597A8 (en) Benzimidazole compounds and their use as estrogen agonists/antagonists
IL166586A0 (en) Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction
AU2003287880A8 (en) Cyclic quinoline compounds for use in mch receptor related disorders
EP1806147A4 (en) USE OF IMMUNOSUPPRESSIVE RECEPTOR
PL378753A1 (pl) Antagoniści receptora CCR-3
IL164016A0 (en) Azetidine derivatives as ccr-3 receptor antagonists
SG131115A1 (en) Method of treating ischemia reperfusion injury using adenosine receptor antagonists
AU2003300904A8 (en) Antagonists for human prolactin
HK1085926A1 (en) Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
SG131946A1 (en) Ccr3 receptor antagonists
GB0203412D0 (en) 5-HT 2B receptor antagonists
EP1696949A4 (en) VEGF Receptor Antagonists
SI1594520T1 (sl) Uporaba antagonistov bradikinin-B2 receptorja za zdravljenje osteoartroze
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
GB0302094D0 (en) EP4 receptor antagonists

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150123